Ray Rosal

Ray Rosal has worked in a variety of roles across multiple companies since 2014. Their first role was as a Summer Intern at RKA Petroleum Companies in 2015. Ray then worked as a Summer Intern at Thomas Duke Company in 2014. In 2016, they worked as an Analyst at Concorde Investment Services. From 2017 to 2021, they worked at Esperion - The Lipid Management Company in various roles, including Senior Business Development Associate, Senior Financial Analyst, and Financial Analyst. Most recently, they have been working as the Business Development & Strategy Manager at METiS Therapeutics since 2021.

Ray Rosal has a background in education from the University of Michigan. Ray also holds two certifications from the Financial Industry Regulatory Authority (FINRA): a Series 66 obtained in January 2017 and a Series 7 obtained in December 2016.